Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05241522 · ClinicalTrials.gov registry record · Phase 1
Dosimetry of Tc-99m-Tilmanocept
A Phase 1 study of Diabetic Kidney Disease, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05241522 is a Phase 1 study of Diabetic Kidney Disease that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 120 participants, below the 5,185-participant average among 23 other Diabetic Kidney Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05241522, a Phase 1 study of Diabetic Kidney Disease, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposal will use kidney SPECT/CT of Tc-99m-tilmanocept to evaluate the mesangial changes seen in diabetics across the spectrum of kidney disease as well as persons with hypertensive kidney disease, the next most common cause of kidney disease in patients with diabetes. We aim to demonstrate that these different disease types and stages can be differentiated with Tc-99m-tilmanocept SPECT/CT and can thus be used for future trials evaluating early diagnosis and treatment of diabetic nephropathy.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Tc-99m-Tilmanocept
Study Locations (1)
California
- UC San Diego Medical Center - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2021-08-06 |
| Est. Completion | 2024-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05241522
The ClinicalTrials.gov registry entry for NCT05241522 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,185-participant average among 23 other Diabetic Kidney Disease trials with a reported enrollment target (98% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which Tc-99m-Tilmanocept is the first listed.
NCT05241522 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05241522 about?
NCT05241522 is a clinical study titled "Dosimetry of Tc-99m-Tilmanocept". This proposal will use kidney SPECT/CT of Tc-99m-tilmanocept to evaluate the mesangial changes seen in diabetics across the spectrum of kidney disease as well as persons with hypertensive kidney disease, the next most common cause of kidney disease in patients with diabetes. We aim to demonstrate th...
What is the current status of trial NCT05241522?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 120 participants. The study started on 2021-08-06. Estimated completion is 2024-12-31.
What conditions does trial NCT05241522 study?
This clinical trial studies the following conditions: Diabetic Kidney Disease.
What interventions are being tested in trial NCT05241522?
The interventions under investigation include: Tc-99m-Tilmanocept (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05241522?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05241522 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
COMPLETED · Phase 1
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
RECRUITING
-
Formoterol in Diabetes
RECRUITING · Phase 2
-
Mechanism of SGLT2 Inhibition in the Kidney
RECRUITING · Phase 4
-
A Long-Term Follow-Up Study of Participants Exposed to REACT
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.